Abstract: The invention relates to 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) for use as a medicament, pharmaceutical compositions comprising at least a compound of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to substituted 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) for use as a medicament, pharmaceutical compositions comprising the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) for use as a medicament, pharmaceutical compositions comprising at least a compound of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to substituted 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) for use as a medicament, pharmaceutical compositions comprising the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: Methods for controlling weeds in sugar cane plantations, wherein at least one herbicide (A) is applied as solid agrochemical formulation (B) to the plantation; and solid agrochemical formulations (B), which are dry, ready for use granules, comprising at least one herbicide (A) selected from metribuzin, diuron, bentazone, hexazinone, tebuthiuron, sulfentrazone, imazapic, imazapyr, glyphosate, MSMA, ametryn, clomazone, isoxaflutole, mesotrione, amicarbazone, atrazine, paraquat, 2,4-D, pendimethalin, saflufenacil and 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione (CAS 1258836-72-4) and at least one carrier (C) selected from the groups (C1) to (C7): (C1) organic based materials (botanicals); (C2) fertilizers; (C3) clays; (C4) carbonates; (C5) sulfates; (C6) synthetic of synthetically modified minerals; (C7) synthetic polymers, polymer dispersions and superabsorbent polymers.

Abstract: A process for the production of pulverulent phytosterol formulations, includes preparing an aqueous solution, suspension or dispersion of the phytosterol in an aqueous molecular dispersion or colloidal dispersion of a protective colloid and drying.

Abstract: A process is described for producing solid preparations of at least one water-soluble, sparingly water-soluble or water-insoluble active compound suitable for the food and animal feed sectors or for pharmaceutical and cosmetic applications. In addition, the invention relates to oily suspensions in which these preparations are present as disperse phase, and to the use of these preparations as additive to animal feeds, foods, pharmaceuticals and cosmetic preparations.

Abstract: The invention relates to a process for producing dry powders of one or more carotenoids by a) dispersing one or more carotenoids in an aqueous molecular or colloidal solution of a mixture of lactose and a protective colloid and b) converting the dispersion which has formed into a dry powder by removing the water and, where appropriate, additionally used solvents and drying, where appropriate in the presence of a coating material, wherein at least one soybean protein is used as protective colloid in process step a).

Abstract: Carotenoid formulations comprising a mixture of ?-carotene, lycopene and lutein, and the use thereof in human and animal foods, cosmetics and pharmaceuticals.

Abstract: Dry microorganism cultures comprising at least one microorganism species in carrier-bound form are present in the form of particles which a) have a particle size of at least about 0.1 mm and b) are compressed; processes for preparing dry microorganism cultures and their use for preparing foodstuffs and feedstuffs are also claimed.

Abstract: A pulverulent phytosterol formulation comprising at least one phytosterol having a mean particle size ranging from 0.01 to 100 ?m, a process for producing the pulverulent phytosterol formulation, and a food supplement, an animal feed, food or pharmaceutical or cosmetic preparation comprising the phytosterol formulation.

Abstract: A description is given of oily suspensions of at least one water-soluble enzyme and of a process for preparing these suspensions and of their use as additive to animal feeds.

Abstract: A process is described for preparing dry powders of one or more oxygenated carotenoids by a) dispersing one or more oxygenated carotenoids in an aqueous molecular dispersion or colloidal dispersion of a protecting colloid and b) converting the dispersion formed into a dry powder by removing the water and any solvents additionally used and drying, in the presence or absence of a coating material, which comprises using as protecting colloid in process step a) at least one partially hydrolyzed soybean protein having a degree of hydrolysis greater than 5%.

Abstract: The invention relates to a method of producing oily suspensions of water-soluble vitamins which comprises

Abstract: Carotenoid formulations comprising a mixture of &bgr;-carotene, lycopene and lutein, and the use thereof in human and animal foods, cosmetics and pharmaceuticals.

Abstract: Carotenoid formulations comprising a mixture of &bgr;-carotene, lycopene and lutein, and the use thereof in human and animal foods, cosmetics and pharmaceuticals.

Abstract: A process is described for preparing dry powders of one or more oxygenated carotenoids by

Abstract: A solid crop protection composition consisting essentially of a) one or more predominantly amorphous crop protection active ingredients which are solid per se and have solubility in water of less than 500 mg/l at 25° C. and b) a coating enclosing component (a).

Abstract: The invention relates to a process for producing dry powders of one or more carotenoids by

Abstract: A process is described for producing solid preparations of at least one water-soluble, sparingly water-soluble or water-insoluble active compound suitable for the food and animal feed sectors or for pharmaceutical and cosmetic applications. In addition, the invention relates to oily suspensions in which these preparations are present as disperse phase, and to the use of these preparations as additive to animal feeds, foods, pharmaceuticals and cosmetic preparations.